Opinion
Video
Switching patients to JAK Inhibitors in Atopic Dermatitis in Clinical Practice
Author(s):
Key Takeaways
- Dermatologists' comfort with JAK inhibitors is influenced by familiarity and patient-specific factors, affecting their willingness to switch treatments.
- Switching from biologics to JAK inhibitors is determined by treatment response, side effects, and patient preferences.
Medical experts rate dermatologists’ comfort with switching to JAK inhibitors and describe how frequently to switch patients from biologics to JAK inhibitors, including their treatment strategy for this population.
Video content above is prompted by the following:
- How would you rate dermatologists’ comfort in switching to a JAK inhibitor?
- How often do you have to switch patients from biologics to JAK inhibitors?
- What is your treatment strategy for this patient population?
Related Videos
Related Content
